Meeting summary: Possibilities for active and passive vaccination against opportunistic infections

[...]Dr. von Specht described a recombinant OMP vaccine that was safe and immunogenic in burn patients. High titered opsonic antibody was produced to multiple strains of S. aureus and S. epidermidis when this antigen was coupled with diptheria toxin to produce a conjugate vaccine.\n Application of emerging technologies to immunologic control of opportunistic infections Current vaccine candidates in advanced development for opportunistic pathogens are relatively immunogenic, but new developments in immunomodulation deserve consideration for future use.